Learn More
Lkt Laboratories CAS 1197-18-8, ≥98%, Plasminogen inhibitor used to decrease blood loss in cardiac surgery and trauma.

Supplier: Lkt Laboratories T6811
Tranexamic acid is clinically used to decrease blood loss in cardiac surgery and trauma; it inhibits plasmin/plasminogen. In vivo, tranexamic acid inhibits fibrinolysis, decreases bleeding time, and increases thrombus formation. Additionally, tranexamic acid accelerates skin barrier recovery and upregulates occluding expression in UV-damaged skin.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.